Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 6-MTH group results

Nov 9 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             19.12               32.59            45.50    
                 (-41.3 pct)         (+3.3 pct)       (-41.8 pct) 
  Operating          1.41               10.87             3.00    
                 (-87.0 pct)         (-22.9 pct)      (-85.4 pct) 
  Recurring          1.60               10.96             3.20    
                 (-85.4 pct)         (-23.1 pct)      (-84.5 pct) 
  Net                1.08                8.54             2.00    
                 (-87.3 pct)         (-14.7 pct)      (-87.5 pct) 
  EPS             9.00 yen            70.91 yen        16.61 yen  
  Ann Div                             42.00 yen        17.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             42.00 yen        17.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news